Pacer Advisors Inc. Has $24.03 Million Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Pacer Advisors Inc. raised its position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 3.6% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 46,034 shares of the medical equipment provider's stock after purchasing an additional 1,620 shares during the period. Pacer Advisors Inc.'s holdings in Intuitive Surgical were worth $24,028,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently made changes to their positions in ISRG. United Asset Strategies Inc. grew its stake in Intuitive Surgical by 1.1% in the 4th quarter. United Asset Strategies Inc. now owns 2,408 shares of the medical equipment provider's stock worth $1,257,000 after buying an additional 27 shares in the last quarter. Cornerstone Wealth Group LLC lifted its holdings in shares of Intuitive Surgical by 0.3% during the 4th quarter. Cornerstone Wealth Group LLC now owns 12,854 shares of the medical equipment provider's stock worth $6,709,000 after acquiring an additional 33 shares during the last quarter. Atticus Wealth Management LLC grew its position in Intuitive Surgical by 14.2% in the fourth quarter. Atticus Wealth Management LLC now owns 403 shares of the medical equipment provider's stock worth $210,000 after acquiring an additional 50 shares in the last quarter. Union Bancaire Privee UBP SA purchased a new stake in Intuitive Surgical during the fourth quarter valued at about $6,509,000. Finally, Blue Trust Inc. boosted its holdings in shares of Intuitive Surgical by 27.2% in the 4th quarter. Blue Trust Inc. now owns 4,747 shares of the medical equipment provider's stock worth $2,332,000 after purchasing an additional 1,014 shares in the last quarter. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at Intuitive Surgical

In related news, CFO Jamie Samath sold 108 shares of the firm's stock in a transaction that occurred on Tuesday, November 26th. The shares were sold at an average price of $542.06, for a total transaction of $58,542.48. Following the transaction, the chief financial officer now owns 8,757 shares in the company, valued at $4,746,819.42. This trade represents a 1.22 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Gary S. Guthart sold 18,151 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, October 30th. The stock was sold at an average price of $511.63, for a total transaction of $9,286,596.13. Following the completion of the transaction, the chief executive officer now directly owns 24,219 shares in the company, valued at $12,391,166.97. This represents a 42.84 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 42,265 shares of company stock valued at $21,964,281 over the last 90 days. 0.90% of the stock is owned by corporate insiders.

Intuitive Surgical Price Performance

NASDAQ:ISRG traded up $0.66 on Tuesday, reaching $574.14. The stock had a trading volume of 2,331,432 shares, compared to its average volume of 2,043,553. The company has a market cap of $204.50 billion, a price-to-earnings ratio of 92.31, a P/E/G ratio of 5.19 and a beta of 1.39. The firm's fifty day moving average is $548.00 and its two-hundred day moving average is $506.12. Intuitive Surgical, Inc. has a 12-month low of $364.17 and a 12-month high of $616.00.

Analyst Ratings Changes

ISRG has been the topic of a number of analyst reports. Leerink Partners boosted their price objective on shares of Intuitive Surgical from $490.00 to $548.00 in a research report on Monday. Mizuho boosted their price objective on shares of Intuitive Surgical from $440.00 to $500.00 in a research report on Thursday, October 17th. Royal Bank of Canada raised their target price on shares of Intuitive Surgical from $611.00 to $641.00 in a research report on Monday. JPMorgan Chase & Co. boosted their price target on shares of Intuitive Surgical from $575.00 to $675.00 and gave the company an "overweight" rating in a research report on Friday. Finally, Truist Financial raised their price objective on shares of Intuitive Surgical from $640.00 to $666.00 and gave the stock a "buy" rating in a report on Friday. One analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have given a buy rating to the company's stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $613.10.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.